Amgen, Inc.

( )
AMGN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 3.28%334.840.0%$4823.21m
BNTXBioNTech SE 5.41%261.090.0%$769.86m
NVAXNovavax, Inc. 2.66%166.2579.4%$734.23m
AMGNAmgen, Inc. -2.27%203.131.4%$562.61m
SNSSSunesis Pharmaceuticals, Inc. -3.25%6.260.7%$437.60m
GILDGilead Sciences, Inc. -2.56%65.901.0%$415.54m
REGNRegeneron Pharmaceuticals, Inc. -1.76%543.482.7%$401.78m
ILMNIllumina, Inc. 0.15%410.533.3%$393.44m
CCXIChemoCentryx, Inc. -5.92%32.432.9%$364.70m
XLRNAcceleron Pharma, Inc. 0.04%173.005.3%$345.57m
VRTXVertex Pharmaceuticals, Inc. -0.53%180.801.9%$258.21m
BIIBBiogen, Inc. -4.08%269.731.7%$233.47m
OCGNOcugen, Inc. -4.62%8.260.0%$170.13m
XENEXenon Pharmaceuticals, Inc. -8.73%30.720.4%$162.62m
CRSPCRISPR Therapeutics AG -0.81%96.210.6%$151.63m

Company Profile

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, Aimovig, KANJINTI, EVENITY, AMGEVITA, AVSOLA, BLINCYTO, MVASI, Corlanor, Enbrel, EPOGEN, IMLYGIC, Kyprolis, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, Otezla, RIABNI, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.